Eli Lilly (LLY) stock surges after releasing promising test results from the company’s GLP-1 pill, which would serve as an alternative to injectable weight-loss drugs. Novo Nordisk (NVO) and Hims & Hers Health (HIMS) stocks are falling on the news.

Yahoo Finance Senior Healthcare Reporter Anjalee Khemlani joins Morning Brief to break down the details.

To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.